These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6731457)

  • 41. The availability of antibiotics in combination with other additives in intravenous solutions.
    Dancey JW; Carew DP
    Am J Hosp Pharm; 1966 Oct; 23(10):543-51. PubMed ID: 5915776
    [No Abstract]   [Full Text] [Related]  

  • 42. Avoiding common flaws in stability and compatibility studies of injectable drugs.
    Trissel LA
    Am J Hosp Pharm; 1983 Jul; 40(7):1159-60. PubMed ID: 6881152
    [No Abstract]   [Full Text] [Related]  

  • 43. Comments: i.v. drug compatibility.
    Drug Intell Clin Pharm; 1986 Sep; 20(9):714-5. PubMed ID: 3757789
    [No Abstract]   [Full Text] [Related]  

  • 44. Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
    Bell MS; Nolt DH
    Am J Health Syst Pharm; 2003 Jan; 60(2):193-4. PubMed ID: 12561666
    [No Abstract]   [Full Text] [Related]  

  • 45. Visual compatibility of amphotericin B and flush solutions.
    Rice JK
    Am J Hosp Pharm; 1989 Dec; 46(12):2461. PubMed ID: 2603876
    [No Abstract]   [Full Text] [Related]  

  • 46. Visual compatibility of warfarin sodium injection with selected medications and solutions.
    Bahal SM; Lee TJ; McGinnes M; Dobler GL
    Am J Health Syst Pharm; 1997 Nov; 54(22):2599-600. PubMed ID: 9397223
    [No Abstract]   [Full Text] [Related]  

  • 47. Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
    Hassan E; Leslie J; Martir-Herrero ML
    Am J Hosp Pharm; 1994 Sep; 51(17):2143-5. PubMed ID: 7985689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visual compatibility of cibenzoline succinate with commonly used acute-care medications.
    Dahl JM; Roche VF; Hilleman DE
    Am J Hosp Pharm; 1987 May; 44(5):1123-5. PubMed ID: 3605123
    [No Abstract]   [Full Text] [Related]  

  • 49. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Feb; 50(2):300-4. PubMed ID: 8097617
    [No Abstract]   [Full Text] [Related]  

  • 50. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visual compatibility of perphenazine with various antimicrobials during simulated Y-site injection.
    Gasca M; Fanikos J; Souney PF
    Am J Hosp Pharm; 1987 Mar; 44(3):574-5. PubMed ID: 3565416
    [No Abstract]   [Full Text] [Related]  

  • 52. A pH pattern for I.V. additives.
    Webb JW
    Am J Hosp Pharm; 1969 Jan; 26(1):31-5. PubMed ID: 5763886
    [No Abstract]   [Full Text] [Related]  

  • 53. Precipitation in Gallipoli: sugammadex / amiodarone & sugammadex / dobutamine & sugammadex / protamine.
    Hancı V; Kiraz HA; Ömür D; Ekin S; Uyan B; Yurtlu BS
    Braz J Anesthesiol; 2013 Jan; 63(1):163-4. PubMed ID: 24565100
    [No Abstract]   [Full Text] [Related]  

  • 54. Toxicity of corticosteroids and catecholamines for mice neuronal cell cultures: Role of preservatives.
    Dani C; Vestri V; Bertini G; Pratesi S; Rubaltelli FF
    J Matern Fetal Neonatal Med; 2007 Apr; 20(4):325-33. PubMed ID: 17437241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compatibility of amphotericin B with drugs used to reduce adverse reactions.
    Gotz VP; Mar DD; Roche JJ
    Am J Hosp Pharm; 1981 Mar; 38(3):378-9. PubMed ID: 7223754
    [No Abstract]   [Full Text] [Related]  

  • 56. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
    Jay GT; Fanikos J; Souney PF
    Am J Hosp Pharm; 1988 Jul; 45(7):1556-7. PubMed ID: 3414721
    [No Abstract]   [Full Text] [Related]  

  • 57. Cimetidine hydrochloride compatibility. III: Room temperature stability in drug admixtures.
    Yuhas EM; Lofton FT; Rosenberg HA; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1981 Dec; 38(12):1919-22. PubMed ID: 7325173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Visual compatibility of premixed theophylline or heparin with selected drugs for i.v. administration.
    Kershaw BP; Monnier HL; Mason JH
    Am J Hosp Pharm; 1993 Jul; 50(7):1360, 1362-3. PubMed ID: 8362868
    [No Abstract]   [Full Text] [Related]  

  • 59. Stability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministration.
    Johnson CE; Bhatt-Mehta V; Mancari SC; McKown JA
    Am J Hosp Pharm; 1994 Nov; 51(22):2812-5. PubMed ID: 7856605
    [No Abstract]   [Full Text] [Related]  

  • 60. [Preparation of a compatibility chart for intravenous drug therapy in neonatal and pediatric intensive care units].
    Höpner JH; Schulte A; Thiessen J; Knuf M; Huth RG
    Klin Padiatr; 2007; 219(1):37-43. PubMed ID: 17205430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.